From superbugs to MRSA, cautious antibiotic use can help
Watch as two ODs explain their protocol for dealing with red eye in light of antibiotic resistance.
Milton Hom, OD, FAAO, shares why optometrists should care about antibiotic resistance.
It’s been a busy week for ophthalmology research and news after both the Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Seattle and the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in New Orleans.
Optometry Times Editorial Advisory Board member Katherine M. Mastrota, MS, OD, FAAO explains the mechanism of antibiotic resistance and its importance to eyecare practitioners.
Anyone who treats ocular surface disease (OSD) recognizes the important role oral antibiotics play in therapy, especially in patients with meibomian gland dysfunction (MGD). Yet the existing evidence is insufficient to conclude the effectiveness of oral antibiotic therapy, according to a report published in Ophthalmology.
During the ARVO meeting last week, Bausch + Lomb researchers presented results from the 5th Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study in the United States, as well as the first data from the study in Canada.
Study researchers say that resistance rates have remained stable; however, more than 33% of certain isolates were resistant to three or more antibiotics.